Nature Biotechnology publication details improved calibration framework for deep learning-based genetic perturbation models
New Ancora assays for oncology produce precision results with MRD-grade sensitivity, delivering the full biological picture for every sample
The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics (CDx) and laboratory infrastructure, supporting active programs with leading pharma partners
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people
New portfolio aims to support biosimilar developers accelerate the path to analytical similarity and improve process economics
A validated bioassay that worked yesterday is not guaranteed to work tomorrow, and CRO Prolytix is urging the industry to rethink what ‘validated’ really means
PakScan brings configurable test layouts, low-headspace capability, and a smaller footprint to PACK EXPO International 2026
IPN60330 is a bispecific antibody engaging MAIT cells, a subset of non-conventional T cells present throughout the body, and the clinically validated tumor antigen GPC3 to kill cancer cells across a variety of solid tumors
Roche and Genentech have signed a 10-year lease for the 95,000 square metre center, which will have capacity for up to 500 people across research, clinical development, data science, and AI, to drive innovation in drug discovery and development
Cutting-edge technologies and collaborative research are transforming how scientists overcome genomic instability and accelerate therapeutic protein production
Optimized mRNA constructs are designed for high on-target editing, reduced off-target activity with SpyFi, low toxicity, and delivery method flexibility
Dr. Catherine McKeen of LGC Diagnostics & Genomics - Biosearch Technologies Oligo Synthesis explains how solid support chemistry influences oligonucleotide yield and purity, and how customer collaboration shaped the development of PrimeMax™ CPG
Evotec experts explain why early de-risking is more than avoiding failure, it is about helping the right drug candidates succeed
Connected data and traceable decisions are becoming vital in a new era of pharmaceutical development, AI, and advanced therapies
Pilot study to develop prototype agentic AI sub-system for initial validation screening of targets identified using AI predictive genomics platform, Nomaly
Zetasizer Core is the first instrument to measure DLS, SLS and DSF on a standard well plate, showing biologics teams not just whether a candidate is unstable, but the mechanisms driving it
Acquisition strengthens Revvity’s position in human-relevant life sciences tools for next-generation GLP-1 and GPCR-targeting therapies for metabolic drug discovery
New survey data reveals what scientists value most when sourcing chemical raw materials, and where Glentham Life Sciences is closing the gaps
New synthetic cell-mimic controls enable researchers to achieve reproducible results across multiple sites and instruments
Learn how advances in massively parallel oligo synthesis are driving protein engineering, synthetic gene assembly, and functional genomics research
First trial of its kind finds heart function remained stable after recovery from treatment-related heart problems one year after stopping medication
See how Life Science Group and Absolute Antibody partner to deliver a flexible antibody offering for future-focused life sciences research
Alfa Chemistry highlights a key challenge in natural-product drug discovery: ensuring reliable access to well-characterized compounds, enabling SAR studies, biological validation, and progression of promising leads
Extended range of process-scale columns prepacked with CEX, AEX, CEX-HIC, and AEX-HIC chromatography resins provides an effective solution for purification of biomolecules in downstream processing
